唐人神(002567) - 2021 Q3 - 季度财报
TRSTRS(SZ:002567)2021-10-27 16:00

Financial Performance - The company's operating revenue for Q3 2021 was ¥5,421,636,129.14, an increase of 0.88% year-on-year, while the revenue for the year-to-date reached ¥16,255,337,388.56, representing a 22.50% increase compared to the same period last year [4] - The net profit attributable to shareholders for Q3 2021 was -¥573,400,557.56, a decrease of 308.78% year-on-year, and the year-to-date net profit was -¥397,630,522.30, down 156.29% compared to the previous year [4] - The company's basic earnings per share for Q3 2021 was -¥0.4962, reflecting a decline of 419.10% year-on-year, while the diluted earnings per share also stood at -¥0.4962, down 419.10% [7] - Total operating revenue for the current period reached ¥16,264,381,377.78, an increase of 22.5% compared to ¥13,277,661,112.45 in the previous period [51] - Total operating costs amounted to ¥16,404,161,112.02, up 31.5% from ¥12,449,491,252.80 in the previous period [51] - Net profit for the current period was -¥378,586,344.15, a significant decrease from a net profit of ¥815,282,186.02 in the previous period [57] - The total comprehensive income attributable to the parent company was -¥397,630,522.30, compared to ¥706,502,344.50 in the previous period [63] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date was -¥148,810,962.19, a decrease of 123.32% compared to the same period last year [7] - Cash inflow from operating activities totaled ¥18,438,713,519.70, an increase from ¥13,366,501,463.55 in the previous period [66] - Net cash outflow from operating activities was 18,587,524,481.89 CNY, compared to 12,728,315,488.47 CNY in the previous period, indicating a significant increase in cash outflow [69] - The company reported a net increase in cash and cash equivalents of 1,751,014,984.77 CNY, compared to 613,124,514.39 CNY in the previous period, indicating improved liquidity [75] - Cash and cash equivalents at the end of the period totaled 2,767,900,792.57 CNY, compared to 1,355,647,195.60 CNY at the end of the previous period, showing a significant increase [75] Assets and Liabilities - Total assets at the end of Q3 2021 were ¥15,203,165,042.59, an increase of 47.89% from the end of the previous year [7] - The company's total assets as of September 30, 2021, were RMB 15,203,165,042.59, compared to RMB 10,280,076,176.12 at the end of 2020, reflecting a growth of approximately 47.5% [38] - The total liabilities increased to RMB 8,267,384,641.00 from RMB 4,419,662,413.77, marking a rise of about 87.5% [44] - The company's long-term borrowings increased by 186% compared to the beginning of the year, indicating a shift in debt structure towards long-term financing [15] - The company's long-term borrowings surged to RMB 3,706,984,680.80 from RMB 1,293,626,838.36, indicating a growth of about 187.5% [43] - Total liabilities amounted to approximately CNY 4.42 billion, a decrease of CNY 213.46 million compared to the previous period [93] Inventory and Assets Management - The company has recognized inventory impairment provisions due to the continuous decline in pig prices, impacting profitability in the breeding business [15] - The inventory as of September 30, 2021, was RMB 2,138,478,932.58, compared to RMB 1,844,090,201.22 at the end of 2020, showing an increase of approximately 16% [32] - The company reported a significant increase of 95% in construction in progress compared to the beginning of the year, reflecting ongoing investments in feed and breeding projects [13] - The company reported a 36% increase in biological assets compared to the beginning of the year, attributed to an increase in the number of breeding sows [15] Shareholder Activities - The company repurchased 7,152,148 shares, accounting for 0.59% of the total share capital, with a total transaction amount of RMB 45,354,136.04 [27] - The company issued 226,939,960 new shares through a private placement, which were listed on March 8, 2021, and the shares were released from restrictions on September 9, 2021 [27] Expenses - Research and development expenses increased to ¥150,798,391.90, compared to ¥131,840,059.24 in the previous period, reflecting a growth of 14.4% [54] - The company reported a significant increase in sales expenses, which rose to ¥471,517,571.51 from ¥384,710,118.60 in the previous period [54] - The company experienced a substantial increase in financial expenses, which reached ¥103,587,435.52, compared to ¥53,236,464.55 in the previous period [54] - The company paid 872,100,878.19 CNY to employees, an increase from 666,782,937.14 CNY in the previous period, indicating higher employee compensation [69] - Cash paid for taxes was 54,251,806.42 CNY, up from 46,905,834.14 CNY, reflecting an increase in tax obligations [69]